Charles Chuah

2 ta ish

Singapore General Hospital

1. Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

   Jörge E. Cortes, Giuseppe Saglio, Hagop M. Kantarjian +9

   MaqolaOAOchiq kirish20162 iqtibos

   ABIABI:AkademIndex/2026.other.108166

2. POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial

   Jane F. Apperley, Jörge E. Cortes, Elias Jabbour +21

   MaqolaOAOchiq kirishChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

   ABIABI:AkademIndex/2023.article.010140